CoChat

Investigating G protein signalling bias at the glucagon‐like peptide‐1 receptor in yeast

Open access
Weston, C, Poyner, D, Patel, V, Dowell, S, Ladds, G · 2014 · British Journal of Pharmacology
Cited by 53

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background and Purpose: The glucagon‐like peptide 1 (GLP‐1) receptor performs an important role in glycaemic control, stimulating the release of insulin. It is an attractive target for treating type 2 diabetes. Recently, several reports of adverse side effects following prolonged use of GLP‐1 receptor therapies have emerged: most likely due to an incomplete understanding of signalling complexities. Experimental Approach: We describe the expression of the GLP‐1 receptor in a panel of modified yeast strains that couple receptor activation to cell growth via single G α/yeast chimeras. This assay enables the study of individual ligand–receptor G protein coupling preferences and the quantification of the effect of GLP‐1 receptor ligands on G protein selectivity. Key Results: The GLP‐1 receptor functionally coupled to the chimeras representing the human G αs, G αi and G αq subunits. Calculation of the dissociation constant for a receptor antagonist, exendin‐3 revealed no significant difference between the two systems. We obtained previously unobserved differences in G protein signalling bias for clinically relevant therapeutic agents, liraglutide and exenatide; the latter displaying significant bias for the G αi pathway. We extended the use of the system to investigate small‐molecule allosteric compounds and the closely related glucagon receptor. Conclusions and Implications: These results provide a better understanding of the molecular events involved in GLP‐1 receptor pleiotropic signalling and establish the yeast platform as a robust tool to screen for more selective, efficacious compounds acting at this important class of receptors in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12716

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 53

Metadata

Authors
Weston, C., Poyner, D., Patel, V, Dowell, S., & Ladds, G.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-07-17
Volume
171
Issue
15
Pages
3651-3665
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1933158260
Cited by
53
References
12
FWCI
2.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigating G protein signalling bias at the glucagon‐like peptide‐1 receptor in yeast. https://app.cochat.ai/papers/10.1111/bph.12716
The paper
Weston, C., Poyner, D., Patel, V, Dowell, S., & Ladds, G. (2014). Investigating G protein signalling bias at the glucagon‐like peptide‐1 receptor in yeast. British Journal of Pharmacology. https://doi.org/10.1111/bph.12716

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.